| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Nov 20, 2024 | Buy | $14.19 | 18,750 | 266,102 | 69,843 | Nov 22, 2024, 04:03 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Nov 20, 2024 | Buy | $14.19 | 18,750 | 266,102 | 69,843 | Nov 22, 2024, 04:03 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Nov 19, 2024 | Buy | $14.23 | 34,843 | 495,708 | 51,093 | Nov 22, 2024, 04:03 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Nov 19, 2024 | Buy | $14.23 | 34,843 | 495,708 | 51,093 | Nov 22, 2024, 04:03 PM | |
| INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Director | Oct 03, 2024 | Buy | $15.00 | 6,667 | 100,005 | 20,443 | Oct 07, 2024, 04:34 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 12, 2024 | Buy | $15.05 | 26,963 | 405,793 | 692,511 | Sep 16, 2024, 05:12 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 16, 2024 | Buy | $17.13 | 13,037 | 223,324 | 705,548 | Sep 16, 2024, 05:12 PM | |
| INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Director | Sep 11, 2024 | Buy | $15.07 | 6,457 | 97,307 | 13,776 | Sep 12, 2024, 05:14 PM | |
| INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Director | Sep 10, 2024 | Buy | $15.00 | 179 | 2,685 | 7,319 | Sep 12, 2024, 05:14 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 06, 2024 | Buy | $15.29 | 26,000 | 397,540 | 647,548 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 09, 2024 | Buy | $15.21 | 9,500 | 144,495 | 657,048 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 10, 2024 | Buy | $15.19 | 8,500 | 129,115 | 665,548 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 03, 2024 | Buy | $15.81 | 20,000 | 316,263 | 165,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 29, 2024 | Buy | $14.03 | 10,000 | 140,300 | 135,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 30, 2024 | Buy | $14.02 | 10,000 | 140,200 | 145,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Director | Aug 29, 2024 | Buy | $14.00 | 7,140 | 99,960 | 7,140 | Sep 03, 2024, 04:27 PM | |
| INBX | Inhibrx Biosciences, Inc. | MANHARD KIMBERLY | Director | Aug 28, 2024 | Buy | $13.98 | 10,000 | 139,800 | 10,000 | Aug 30, 2024, 04:16 PM | |
| INBX | Inhibrx Biosciences, Inc. | FORSYTH DOUGLAS | Director | Aug 23, 2024 | Buy | $14.07 | 59,812 | 841,555 | 224,564 | Aug 26, 2024, 04:26 PM | |
| INBX | Inhibrx Biosciences, Inc. | FORSYTH DOUGLAS | Director | Aug 22, 2024 | Buy | $12.89 | 15,188 | 195,773 | 164,752 | Aug 26, 2024, 04:26 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 20, 2024 | Buy | $12.97 | 27,055 | 350,903 | 41,920 | Aug 22, 2024, 04:29 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 21, 2024 | Buy | $12.93 | 12,945 | 167,379 | 54,865 | Aug 22, 2024, 04:29 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Jun 05, 2024 | Buy | $17.32 | 57,549 | 997,024 | 1,150,410 | Jun 07, 2024, 06:05 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Jun 03, 2024 | Buy | $17.43 | 127,530 | 2,222,425 | 1,003,798 | Jun 04, 2024, 05:27 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Jun 04, 2024 | Buy | $17.65 | 89,063 | 1,572,240 | 1,092,861 | Jun 04, 2024, 05:27 PM | |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | May 31, 2024 | Buy | $16.14 | 70,193 | 1,132,915 | 876,268 | Jun 04, 2024, 05:27 PM |
Menu